Search All UT System Experts

A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer

Miguel Martin, Jacques Bonneterre, Charles E. Geyer, Yoshinori Ito, Jungsil Ro, Istvan Lang, Sung Bae Kim, Caroline Germa, Jennifer Vermette, Kenneth Wang, Kongming Wang, Ahmad Awada

Research output: Contribution to journal › Article › peer-review

128 Scopus citations

Fingerprint

Dive into the research topics of 'A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences